Læknablaðið - 15.05.2005, Page 17

FRÆÐIGREINAR / OFVIRKNIRÖSKUN
Þakkir
Þökkum Önnu Helgadóttur lækni og Páli Ólafssyni
bókasafnsfræðingi fyrir veitta aðstoð.
Heimildir
1. Baldursson G, Guömundsson Ó.Ó., Magnússon P. Ofvirkni-
röskun - yfirlitsgrein. Læknablaðið 2000; 86:413-9.
2. The International Statistical Classification of Diseases
and Related Health Problems (ICD-10). Tíunda útgáfa.
Office of Publications, World Health Organization, Geneva.
Switzerland 1992: 262-5.
3. Green M, Wong M, Atkins D. Technical Review Number
3: Diagnosis of Attention Deficit/Hyperactivity Disorder.
AHCPR Publication 99-0050. www.ahrq.gov/clinic/epcsums/
adhdsutr.htm
4. Magnússon P, Smári J, Grétarsdóttir H, Prándardóttir
H. Attention- Deficit/Hyperactivity Symptoms in Icelandic
Schoolchildren: Assessment with the Attention Deficit/
Hyperactivity Rating Scale-IV. Scand J Psychol 1999; 40:301-6.
5. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A,
Spencer T, et al. Influence of gender on attention deficit hyper-
activity disorder in children referred rto a psychiatric clinic.
Am J Psychiatry 2002; 159: 36-42.
6. Faraone SV, Doyle. Genetic influences on attention deficit
hyperactivity disorder. Curr Psychiatry Rep 2000; 2:143-6.
7. Elia J, Ambrosini P, Papoport J. Treatment of attention - defi-
cit-hyperactivity disorder. N Engl J Med 1999; 340:780-8.
8. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski
T, Buitelaar J. European clinical guidelines for hyperkinetic
disorder - first upgrade. Eur Child Adolesc Psychiatry 2004;
13/Suppl. 1:17-130.
9. Montano B. Diagnosis and treatment of ADHD in adults in
primary care. J Clin Psychiatry 2004; 65 Suppl 3:18-21.
10. Comings DE. Clinical and molecular genetics of ADHD and
Tourette syndrome. Two related polygenic disorders. Ann N Y
Acad Sci 2001; 931: 50-83.
11. Gadow KD, Nolan EE, Sprafkin J, Schwartz J. Tics and psychi-
atric comorbidity in children and adolescents. Dev Med Child
Neurolog 2002; 44: 330-8.
12. Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology
of attention-deficit/hyperactivity disorder (ADHD): a public
health view. Ment Retard Dev Disabil Res Rev 2002; 8:162-70.
13. Arnold LE. Contemporary Diagnosis and Management
of Attention-Deficit/Hyperactivity Disorder. Handbooks in
Health Care Co, 2002,22.
14. Faraone SV, Biederman J, Monuteaux C. Toward Guidelines
for Pedigree Selection in Genetic Studies of Attention Deficit
Hypreactivity Disorder. Genetic Epidemiology 2000; 18:1-16.
15. Biederman J, Faraone, S, Keenan K. Further evidence for
family genetic risk factors in attention deficit hyperactivity
disorder. Arch Gen Psychiatry 1992; 49: 728-38.
16. Kuntsi J, Stevenson J. Hyperactivity in Children: Focus on
Genetic Reserch and Psyhological Theories. Clin Child Family
Psychol Rev 2000;1:1-22.
17. Sharp WS, Gottesman RF, Greenstein DK, Ebens CL,
Rapoport JL, Castellanos FX. Monozygotic Twins Discordant
for Attention-Deficit/Hyperactivity Disorder: Ascertainment
and Clinical Characteristics. J Am Acad Child Adolesc
Psychiatry 2003; 42: 93-7.
18. Hauser P, Zametkin A, Martinez P, Viteiello B, Matochik
J, Mixson A, et al. Attention deficit-hyperactivity disorder
in people with gengeralized resistance to thyroid hormone.
NEJM 1993; 328: 997-1001.
19. Bakker SC, Meulen EM, BuitelaarJK, Sandkujil LA, Pauls
DL, Monsuur AJ, et al. A Whole-Genome Scan in 164 Dutch
Sib Pairs with Attention-Deficit/Hyperactivity Disorder:
Suggestive Evidence for Linkage on Chromosomes 7p and
15q. Am J Hum Genet 2003; 72:1251-60.
20. Fisher SE, Francs C, McCracken JT, McGough JJ, Marlow AJ,
MacPhie IL, et al. A Genomwide Scan for Loci Involved in
Attention-Deficit/Hyperactivity Disorder. Am J Hum Genet
2002; 70:1183-96.
21. Zappitelli M, Pinto T, Grizenko N. Pre-, Peri-, and Postnatal
Trauma in Subjects With Attention-Defícit Hyperactivity
Disorder. Can J Psychiatry 2001; 46: 542-8.
22. Wolraich ML, Doffing MA. Pharmacokinetic considerations in
the treatment of attention-deficit hyperactivity disorder with
methylphenidate. CNS Drugs 2004; 18:243-50.
23. Ohno M. The dopaminergic system in attention deficit/hyper-
activity disorder. Congenit Anom Kyoto 2003; 43:114-22.
24. Molecular Genetics of Attention Deficiti Hyperactivity
Disorder. Faraone SV, Perlis RH, Doyle AE, Smoller JW,
Goralnick JJ, Holmgren MA, et al. In press.
25. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-
Analysis of the Association Between the 7-Repeat Allele
of the Dopamine D4 Receptor Gene and Attention Deficit
Hyperactivity Disorder. Am J Psychiatry 2001; 158:1052-7.
26. LaHoste GJ. Dopamine D4 receptor gene polymorphism is
associated with attencion deficit hyperactivity disorder. Mol
Psychiatry 1996; 1: 83-4.
27. Rowe DC, Stever C, Chase D, Sherman S, Abramowitz
A, Waldman ID. Two dopamine genes related to
reports of childhood retrospective inattention and con-
duct disorder symptoms. Mol Psychiatry 2001; 6: 429-33.
Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM,
Kieffer JE, et al. Association of attention-deficit disorder and
the dopamine transporter gene. Am J Hum Genet 1995; 56:
993-8.
28. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras
BK, Fischman AJ. Dopamine transporter density in patients
with attention defícit hyperactivity disorder. Lancet 1999; 354:
2132-3.
29. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K,
Kung HF, et al. Attention deficit hyperactivity disorder: bind-
ing of [99mTc]TRODAT-l to the dopamine transporter before
and after methylphenidate treatment. Eur J Nucl Med 2000;
27:1518-24.
30. Purper-Ouakil D, Wohl M, Mouren MC, Verpillat P, Gorwood
P. Meta-analysis of family-based association studies between
the dopamine transporter gene and attention deficit hyperac-
tivity disorder. Psychiatr Genet 2005; 15: 53-9
31. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar
A, Gritsenko I, et al. Haplotype Relative Risk Study of
CatechoI-LO-Methytltransferase (COMT) and Attention
Deficit Hyperactivity Disorder(ADHD). AM J Med Genet
1999;88:497-502.
32. Diagnostic and Statistical Manual of Mental Disorders, fourth
Edition. (DSM-IV) 1994 American Psychiatric Association.
Washington DC 1994: 63-6.
33. Cook EH Jr, Stein MA, Ellison T, Unis AS, Leventhal BL.
Attention deficit hyperactivity disorder and whole-blood sero-
tonin levels: effects of comorbidity. Psychiatry Res 1995; 57:
13-20.
34. Seeger G, Schloss P, Schmidt MH. Functional polymorphism
within the promotor of the serotonin transporter gene is asso-
ciated with severe hyperkinetic disorders. Mol Psychiatry 2001;
6:235-8.
35. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein
RP, et al. Family-based association study of the serotonin
transporter promoter region polymorphism (5-HTTLPR) in
attention deficit hyperactivity disorder. Am J Med Genet 2001;
105: 91-5.
36. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, et
al. Identification of DNA variants in the SNAP-25 gene and
linkage study of these polymorphisms and attention-deficit
hyperactivity disorder. Mol Psychiatry 2000; 5:405-9.
37. Milberger S, Biederman J, Faraone S, Chen L, Jones J. Is
maternal smoking during pregnancy a risk factor for attention
deficit hyperactivity disorder in children? Am J Psychiatry
1996; 153:1138-42.
38. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-
control study of attention-deficit hyperactivity disorder and
maternal smoking, alcohol use, and drug use during pregnancy.
J Am Acad Child Adolesc Psychiatry 2002; 41: 378-85.
39. Milberger S, Biederman J, Faraone S, Chen L, Jones J. Further
evidence of an association between maternal smoking dur-
ing pregnancy and attention deficit hyperactivity disorder:
Findings from a high-risk sample of siblings. J Clin Child
Psychol 1998; 27:352-8.
40. Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB,
Rodriguez A, et al. Maternal Lifestyle Factors in Pregnancy
Risk of Attention Deficit Hyperactivity Disorder and
Associated Behaviors: Review of the Current Evidence. Am J
Psychiatry 2003; 1601028-40.
41. Streissguth AP, Sampson PD, Olson HC, Bookstein FL, Barr
HM, Scott M. Maternal drinking during pregnancy: attention
and short-term memory in 14-year-old offspring - a longitudi-
nal prospective study. Alcohol Clin Exp Res 1994; 18: 202-18.
42. Hill SY, Lowers L, Locke-Wellman J, Shen SA. Maternal
Smoking and Drinking during Pregnancy and the Risk for
Child and Adolescent Psychiatric Disorders. J Stud Alcohol
2000; 61: 661-8.
43. Burd L, Klug MG, Martsolf JT, Kerbeshian J. Fetal alcohol
syndrome: neuropsychiatric phenomics. Neurotoxicol Teratol
2003; 25: 697-705.
44. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJS.
Cognitive and Behavioral Outcomes of School-Aged Children
Who Were Born Preterm, A Meta-Analysis. JAMA 2002; 288:
728-37.
Læknablaðið 2005/91 413